Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit
Open Access
- 31 May 1991
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (6) , 118-125
- https://doi.org/10.1016/0735-1097(91)90947-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Mechanism of angioplasty and its relation to restenosisThe American Journal of Cardiology, 1987
- Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Effect of heparin on vascular smooth muscle cells. I. Cell metabolismJournal of Cellular Physiology, 1985
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Effect of antiplatelet therapy on restenosis after experimental angioplastyThe American Journal of Cardiology, 1984
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984